Clinical cases, Cognitive studies, Research Strategy

Second AD case “refutes” amyloid primacy, tantalizes with another mutation to protect cognition?

May 19, 2023 — 0 Comments

Clinical Trials, Cognitive studies, Research Strategy

Donanemab beats Aduhelm in amyloid imaging response…does anyone care?

May 2, 2023 — 0 Comments

Clinical Trials, Cognitive studies, Research Strategy

Young Onset Dementia (YOD, not Yoda) / Early Onset (EOAD) 2023: New reviews, but any therapeutic insights?

March 23, 2023 — 0 Comments

Clinical Trials

“Clinical Meaningfulness” in AD clinical trial results: opinions?!

March 10, 2023 — 0 Comments

Clinical Trials, Cognitive studies

Forgetful? Could Meditation-Stress Reduction, Exercise or Education help?

December 15, 2022 — 1 Comment

Clinical Trials

Lecanemab: really any better than Aricept / donepezil?

December 1, 2022 — 0 Comments

Funding, Research Administration, Research Strategy

Alz v Cancer Pt 3: Why the Difference in Survival Results and Clinical Impact?

November 2, 2022 — 0 Comments

Clinical Trials, Research Strategy

Aricept ™/Donepezil: Already ‘Disease-Modifying’ Enough? Where are the combo trials with Monoclonals?

October 20, 2022 — 0 Comments

Clinical Trials

Lecanemab: Déjà Vu?; Could 112 Steps and Multi-vitamins (but not Cocoa) Reduce the Need?

October 5, 2022 — 0 Comments

Clinical cases, Research Strategy

Alz First Survivors (?!?) vs 18M Cancer Survivors [CA vs Alz, Pt. 2]

August 30, 2022 — 0 Comments